These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4311958)

  • 21. [On the study of the toxico-infective properties of Cl. perfringens].
    Khazanova VV
    Lab Delo; 1969; 3():164-7. PubMed ID: 4185182
    [No Abstract]   [Full Text] [Related]  

  • 22. [Synthesis and certain properties of polysaccharides in B. oedematiens & B. perfringens].
    IVANOV VI; VOLCHOK AK; LOBANOVA AV
    Biokhimiia; 1956; 21(6):760-3. PubMed ID: 13445781
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of antibiotics in combination with antiperfringens serum in the treatment of experimental gas infection caused by Cl. perfringens in association with Escherichia coli].
    Solov'ev SV; Matveev KI
    Eksp Khir Anesteziol; 1969; 14(1):41-3. PubMed ID: 4314241
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of clostridial hemolysin formed in vivo.
    Noyes HE; Easterling R
    J Bacteriol; 1967 Apr; 93(4):1254-61. PubMed ID: 4291766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of glucose and of pH on enzymatic decomposition of lecithin and on synthesis of lecithinase by Cl. perfringens and by Cl. sordellii].
    ALBRYCHT P; MEISEL H; TREMBOWLER P
    Med Dosw Mikrobiol; 1956; 8(4):473-82. PubMed ID: 13399801
    [No Abstract]   [Full Text] [Related]  

  • 26. [The occurrence and significance of enterotoxin-producing Clostridium perfringens strains in the intestinal tract of horses].
    Gautsch S; Beckmann G; Amtsberg G; Dieckmann M; Deegen E
    Berl Munch Tierarztl Wochenschr; 1993 Jan; 106(1):1-6. PubMed ID: 8431197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [OBSERVATIONS ON SPECIFIC THERAPY OF MIXED EXPERIMENTAL INFECTION CAUSED BY CL. PERFRINGENS AND OEDEMATIENS].
    MINERVIN SM; ZHAK SP
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Mar; 41():114-8. PubMed ID: 14187936
    [No Abstract]   [Full Text] [Related]  

  • 28. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bacteriologic diagnosis of Clostridium perfringens infection].
    Sebald M
    Rev Prat; 1990 Mar; 40(7):689-90. PubMed ID: 2183343
    [No Abstract]   [Full Text] [Related]  

  • 30. [Observations on the formation in mixed cultures of hemotoxins of Cl. perfringens and oedematiens].
    Zanchevskaia TA
    Zh Mikrobiol Epidemiol Immunobiol; 1964 May; 41(5):105-9. PubMed ID: 4286366
    [No Abstract]   [Full Text] [Related]  

  • 31. [Toxin formation by Cl. perfringens type E].
    Zemlianitskaia EP; Matveev KI; Tsurikov FF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060
    [No Abstract]   [Full Text] [Related]  

  • 32. [Guinea pig diseases caused by Cl. perfringens type A].
    Nedjalkov S; Draganov M; Pejtschev B
    Arch Exp Veterinarmed; 1966 Apr; 20(2):323-5. PubMed ID: 4296802
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of the effect of Cl. sporogenes proteinases on the hemolytic activity of Cl. perfringens type A toxin].
    Zhak SP; Datsenko MF
    Mikrobiol Zh; 1968; 30(6):566-8. PubMed ID: 4308969
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes in the electrical activity of the cerebral cortex under the combined influence of Cl. perfringens type A toxin and products of Cl. butyricum activity].
    Tselukh AV; Makul'kon RF; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1976; 82(11):1305-10. PubMed ID: 189855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium oedematiens: observations on potency assaying.
    Macheak ME
    Dev Biol Stand; 1976; 32():103-12. PubMed ID: 1001824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal necrotizing enteritis with hepatic and splenic infarction associated with Clostridium perfringens type A in a guinea pig raised in a conventional environment.
    Feldman SH; Songer JG; Bueschel D; Weisbroth SP; Weisbroth SH
    Lab Anim Sci; 1997 Oct; 47(5):540-4. PubMed ID: 9355100
    [No Abstract]   [Full Text] [Related]  

  • 37. [Formation of toxins by Clostridium perfringens types C and D].
    Urguev KR
    Veterinariia; 1970 Jun; 6():98-9. PubMed ID: 4320342
    [No Abstract]   [Full Text] [Related]  

  • 38. [Role of Cl. perfringens types A, B, C, D, E and F in the etiology of gas gangrene].
    Marasanova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Aug; 48(8):116-21. PubMed ID: 4329186
    [No Abstract]   [Full Text] [Related]  

  • 39. [Some data in favor of the enzymatic nature of Cl. perfringens and oedematiens toxins].
    Zhak SP
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Nov; 42(11):65-9. PubMed ID: 4290470
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of a multicomponent standard for clostridial vaccines.
    Gray AK
    Dev Biol Stand; 1976; 32():245-50. PubMed ID: 187507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.